+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Analytical Testing Outsourcing Market Research Report by Product Type, Service, End-Users, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5454989
  • Report
  • April 2022
  • Region: Global
  • 199 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Ajinomoto Bio-Pharma
  • AptarGroup, Inc.
  • Boston Analytical, Inc.
  • Catalent, Inc
  • Exova Group PLC
  • Merck KGaA
The Global Pharmaceutical Analytical Testing Outsourcing Market size was estimated at USD 7,143.15 million in 2021, USD 7,798.18 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.34% to reach USD 12,210.47 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Analytical Testing Outsourcing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Active Pharmaceutical Ingredients, Additives, Finished Product, and Raw Materials.
  • Based on Service, the market was studied across Bioanalytical Testing, Method Development & Validation, and Stability Testing. The Bioanalytical Testing is further studied across Clinical and Non-Clinical. The Method Development & Validation is further studied across Extractable & Leachable, Impurity Method, and Technical Consulting. The Stability Testing is further studied across Accelerated Stability Testing, Drug Substance, Photostability Testing, and Stability Indicating Method Validation.
  • Based on End-Users, the market was studied across Biopharmaceuticals, Contract Manufacturing organizations, Others, and Pharmaceuticals.
  • Based on Application, the market was studied across Bio Analytical Testing, Method Development & Validation, Others, and Stability Testing.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Analytical Testing Outsourcing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Analytical Testing Outsourcing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Analytical Testing Outsourcing Market, including Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Aztech Sciences Inc., Boston Analytical, Inc., Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Eurofins Scientific, Exova Group PLC, Intertek Group PLC, Merck KGaA, Pace Analytical Services, Inc., Pharmaceutical Product Development, LLC, Recro Gainesville, SEIKAGAKU CORPORATION, SGS SA, Source BioScience, Toxikon, Inc., West Pharmaceutical Services Inc., and WuXi AppTec, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmaceutical Analytical Testing Outsourcing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Analytical Testing Outsourcing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Analytical Testing Outsourcing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Analytical Testing Outsourcing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Analytical Testing Outsourcing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Analytical Testing Outsourcing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Analytical Testing Outsourcing Market?
Frequently Asked Questions about the Global Pharmaceutical Analytical Testing Outsourcing Market

What is the estimated value of the Global Pharmaceutical Analytical Testing Outsourcing Market?

The Global Pharmaceutical Analytical Testing Outsourcing Market was estimated to be valued at $7143.2 Million in 2021.

What is the growth rate of the Global Pharmaceutical Analytical Testing Outsourcing Market?

The growth rate of the Global Pharmaceutical Analytical Testing Outsourcing Market is 9.3%, with an estimated value of $12210.5 Million by 2027.

What is the forecasted size of the Global Pharmaceutical Analytical Testing Outsourcing Market?

The Global Pharmaceutical Analytical Testing Outsourcing Market is estimated to be worth $12210.5 Million by 2027.

Who are the key companies in the Global Pharmaceutical Analytical Testing Outsourcing Market?

Key companies in the Global Pharmaceutical Analytical Testing Outsourcing Market include Ajinomoto Bio, Pharma, Alcami Corporation, AptarGroup, Inc., Aztech Sciences Inc., Boston Analytical, Inc., Cambrex Corporation, Catalent, Inc and Eurofins Scientific.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ajinomoto Bio-Pharma
  • AptarGroup, Inc.
  • Boston Analytical, Inc.
  • Catalent, Inc
  • Exova Group PLC
  • Merck KGaA

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing research and development in drug discovery and development
5.1.1.2. Rising incidence of cancer and other infectious diseases worldwide
5.1.1.3. Increasing innovation in the pharmaceutical industry
5.1.2. Restraints
5.1.2.1. Relatively high cost involved in drug development
5.1.3. Opportunities
5.1.3.1. Emerging technological advancements in testing procedures for drug development
5.1.3.2. Growing demand of regulatory bodies for analytical details on drugs
5.1.4. Challenges
5.1.4.1. Lack of consistency in the product quality
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Pharmaceutical Analytical Testing Outsourcing Market, by Product Type
6.1. Introduction
6.2. Active Pharmaceutical Ingredients
6.3. Additives
6.4. Finished Product
6.5. Raw Materials
7. Pharmaceutical Analytical Testing Outsourcing Market, by Service
7.1. Introduction
7.2. Bioanalytical Testing
7.2.1. Clinical
7.2.2. Non-Clinical
7.3. Method Development & Validation
7.3.1. Extractable & Leachable
7.3.2. Impurity Method
7.3.3. Technical Consulting
7.4. Stability Testing
7.4.1. Accelerated Stability Testing
7.4.2. Drug Substance
7.4.3. Photostability Testing
7.4.4. Stability Indicating Method Validation
8. Pharmaceutical Analytical Testing Outsourcing Market, by End-Users
8.1. Introduction
8.2. Biopharmaceuticals
8.3. Contract Manufacturing organizations
8.4. Others
8.5. Pharmaceuticals
9. Pharmaceutical Analytical Testing Outsourcing Market, by Application
9.1. Introduction
9.2. Bio Analytical Testing
9.3. Method Development & Validation
9.4. Others
9.5. Stability Testing
10. Americas Pharmaceutical Analytical Testing Outsourcing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Ajinomoto Bio-Pharma
14.2. Alcami Corporation
14.3. AptarGroup, Inc.
14.4. Aztech Sciences Inc.
14.5. Boston Analytical, Inc.
14.6. Cambrex Corporation
14.7. Catalent, Inc
14.8. Charles River Laboratories International, Inc.
14.9. Eurofins Scientific
14.10. Exova Group PLC
14.11. Intertek Group PLC
14.12. Merck KGaA
14.13. Pace Analytical Services, Inc.
14.14. Pharmaceutical Product Development, LLC
14.15. Recro Gainesville
14.16. SEIKAGAKU CORPORATION
14.17. SGS SA
14.18. Source BioScience
14.19. Toxikon, Inc.
14.20. West Pharmaceutical Services Inc.
14.21. WuXi AppTec, Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: DYNAMICS
FIGURE 2. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2021 VS 2027 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2021 VS 2027 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2027
FIGURE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2021 VS 2027 (%)
FIGURE 41. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2021 VS 2027 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2027
FIGURE 43. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 52. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2027
FIGURE 54. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2019-2027 (USD MILLION)
FIGURE 61. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 62. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. UNITED ARAB EMIRATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: FPNV POSITIONING MATRIX
FIGURE 93. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 94. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ADDITIVES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY FINISHED PRODUCT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 66. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY STATE, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 81. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USERS, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 92. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 94. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 97. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 102. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 104. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 108. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 110. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIO ANALYTICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 113. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 115. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 118. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 123. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 124. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 125. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 127. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 140. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 147. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 156. UNITED KINGDOM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 157. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: SCORES
TABLE 158. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: BUSINESS STRATEGY
TABLE 159. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: PRODUCT SATISFACTION
TABLE 160. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: RANKING
TABLE 161. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 162. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: MERGER & ACQUISITION
TABLE 163. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 164. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 165. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: INVESTMENT & FUNDING
TABLE 166. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 167. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Ajinomoto Bio-Pharma
  • Alcami Corporation
  • AptarGroup, Inc.
  • Aztech Sciences Inc.
  • Boston Analytical, Inc.
  • Cambrex Corporation
  • Catalent, Inc
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Exova Group PLC
  • Intertek Group PLC
  • Merck KGaA
  • Pace Analytical Services, Inc.
  • Pharmaceutical Product Development, LLC
  • Recro Gainesville
  • SEIKAGAKU CORPORATION
  • SGS SA
  • Source BioScience
  • Toxikon, Inc.
  • West Pharmaceutical Services Inc.
  • WuXi AppTec, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...